Purchase Order 75N95018P00434

This firm fixed-price purchase order for $18,204.88 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Genscript USA Inc. to obtain cell lines utilizing CRISPR gene editing technology. Specifically, the contract calls for Genscript to generate knockout HEK293 and HepG2 cell lines of the MMAB and MUT genes to support studies for hereditary disorders of vitamin B12 and methylmalonic acid metabolism. No set-aside designation...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to ACGT, Inc., a for-profit, Asian-Pacific American-owned subchapter S corporation, for the production and verification of 5 GLP-grade plasmids. The contract has a ceiling value of $27,300.00 and a period of performance ending on March 13, 2012. ACGT, Inc. is a contract research service company that has previously provided DNA sequencing, PCR DNA purification, and other...

This federal contract award to Cyagen Biomodels LLC, a biotechnology company based in Santa Clara, California, is for the replacement of a previous purchase order from the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The $30,915.00 firm-fixed-price purchase order does not have a set-aside designation. Cyagen Biomodels LLC specializes in providing custom genetic model services to support biomedical research, including the creation of...

This is a $31,400 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Acgt Inc., a For Profit Organization, Asian-Pacific American Owned, Subchapter S Corporation. The contract is for MEGAPREP 5MG supplies, with an ultimate completion date of September 1, 2011. Acgt Inc. has previously provided DNA sequencing, PCR DNA purification, and other molecular biology services to NIAID and the U.S. Department of Agriculture in support...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Firm Fixed Price Purchase Order to GenScript USA Inc., a for-profit biotechnology company, to provide DETECTION OF MUTATION-REACTIVE T CELLS IN PATIENTS WITH METASTATIC CANCERS. The contract has a potential value of $849,989.66 and a completion date of September 21, 2019. The contract does not have a set-aside designation. GenScript USA Inc. has a history of providing customized DNA,...

This federal contract award, with ID 75N92E24P00271, is a purchase order valued at $13,349.00 awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Genecopoeia, Inc., a minority-owned and Asian-Pacific American-owned for-profit manufacturer. The contract is for the procurement of a "GC-K3038-CF GATEWAY PLUS SHUTTLE CLONE FOR STAT4(NM_001243835.2) [WITHOUT STOP CODON] (PURIFIED PLASMID)." The award has a firm fixed price and an ultimate completion date...

Synthego Corporation will deliver customized human cell lines to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under a $22,650 firm fixed price purchase order. Specifically, Synthego will supply vials of immortalized THP-1 cells containing a single nucleotide variant or codon change in the protein coding sequence of an unspecified chromosome. The estimated turnaround time is 17 weeks for this small cell clone order placed under NIAMS' research support...

This firm fixed-price purchase order, valued at $13,199.63, was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of HEK293 knockout cell lines, which are a critical resource for biomedical research supported by the NIDDK. Genscript USA Inc. is an experienced federal contractor, having received numerous prime and subcontract awards from...

This federal contract award to CD Biosciences Inc., a small business research product supplier and contract research organization, is for CD BIOSCIENCES INCRNA DATA ANALYSIS services. The $4,998.00 firm fixed-price purchase order was awarded on February 2, 2018 by the Southeast Area division of a civilian federal agency, with a completion date of February 23, 2018. CD Biosciences, operating under multiple divisions including Creative Biomart, Creative Biolabs, CD Genomics, and Profacgen, has...

This firm fixed-price delivery order was awarded by the Department of the Army Medical Command to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $322,544.00 contract is for the provision of GeneChip HTMG 430PM 24 Well products. Life Technologies has a history of serving as a prime contractor across multiple federal agencies, including the National Institutes of Health, Department of Defense, Department of Agriculture, Department of...